These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
342 related items for PubMed ID: 9341930
21. Tead1 regulates the expression of Peripheral Myelin Protein 22 during Schwann cell development. Lopez-Anido C, Poitelon Y, Gopinath C, Moran JJ, Ma KH, Law WD, Antonellis A, Feltri ML, Svaren J. Hum Mol Genet; 2016 Jul 15; 25(14):3055-3069. PubMed ID: 27288457 [Abstract] [Full Text] [Related]
22. Schwann cell transcript biomarkers for hereditary neuropathy skin biopsies. Svaren J, Moran JJ, Wu X, Zuccarino R, Bacon C, Bai Y, Ramesh R, Gutmann L, Anderson DM, Pavelec D, Shy ME. Ann Neurol; 2019 Jun 15; 85(6):887-898. PubMed ID: 30945774 [Abstract] [Full Text] [Related]
23. Gene dosage effects in hereditary peripheral neuropathy. Expression of peripheral myelin protein 22 in Charcot-Marie-Tooth disease type 1A and hereditary neuropathy with liability to pressure palsies nerve biopsies. Gabriel JM, Erne B, Pareyson D, Sghirlanzoni A, Taroni F, Steck AJ. Neurology; 1997 Dec 15; 49(6):1635-40. PubMed ID: 9409359 [Abstract] [Full Text] [Related]
30. A translatable RNAi-driven gene therapy silences PMP22/Pmp22 genes and improves neuropathy in CMT1A mice. Stavrou M, Kagiava A, Choudury SG, Jennings MJ, Wallace LM, Fowler AM, Heslegrave A, Richter J, Tryfonos C, Christodoulou C, Zetterberg H, Horvath R, Harper SQ, Kleopa KA. J Clin Invest; 2022 Jul 01; 132(13):. PubMed ID: 35579942 [Abstract] [Full Text] [Related]
31. Polytherapy with a combination of three repurposed drugs (PXT3003) down-regulates Pmp22 over-expression and improves myelination, axonal and functional parameters in models of CMT1A neuropathy. Chumakov I, Milet A, Cholet N, Primas G, Boucard A, Pereira Y, Graudens E, Mandel J, Laffaire J, Foucquier J, Glibert F, Bertrand V, Nave KA, Sereda MW, Vial E, Guedj M, Hajj R, Nabirotchkin S, Cohen D. Orphanet J Rare Dis; 2014 Dec 10; 9():201. PubMed ID: 25491744 [Abstract] [Full Text] [Related]
32. Charcot-Marie-Tooth disease and related inherited neuropathies. Murakami T, Garcia CA, Reiter LT, Lupski JR. Medicine (Baltimore); 1996 Sep 10; 75(5):233-50. PubMed ID: 8862346 [Abstract] [Full Text] [Related]
35. The "CMT rat": peripheral neuropathy and dysmyelination caused by transgenic overexpression of PMP22. Niemann S, Sereda MW, Rossner M, Stewart H, Suter U, Meinck HM, Griffiths IR, Nave KA. Ann N Y Acad Sci; 1999 Sep 14; 883():254-61. PubMed ID: 10586250 [Abstract] [Full Text] [Related]
38. MCP-1/CCL2 modifies axon properties in a PMP22-overexpressing mouse model for Charcot-Marie-tooth 1A neuropathy. Kohl B, Fischer S, Groh J, Wessig C, Martini R. Am J Pathol; 2010 Mar 14; 176(3):1390-9. PubMed ID: 20093502 [Abstract] [Full Text] [Related]
39. Differentiation of Human Tonsil-Derived Mesenchymal Stem Cells into Schwann-Like Cells Improves Neuromuscular Function in a Mouse Model of Charcot-Marie-Tooth Disease Type 1A. Park S, Jung N, Myung S, Choi Y, Chung KW, Choi BO, Jung SC. Int J Mol Sci; 2018 Aug 14; 19(8):. PubMed ID: 30110925 [Abstract] [Full Text] [Related]